Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial

References

• Andaluz, A., DeMoss, D., Claassen, C., Blair, S., Hsu, J., Bakre, S., Khan, M., Atem, F., & Rush, A. J. (2020). Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: A retrospective, open-label study. The American Journal of Drug and Alcohol Abuse, 46(1), 49–57. https://doi.org/10.1080/00952990.2019.1634085
   PubMed Web of Science ®Google Scholar
• Chen, C. M., & Yoon, Y. H. (2018). Trends in alcohol-related morbidity among community hospital discharges, United States, 2000–2015. Surveillance Report #112. Retrieved from https://pubs.niaaa.nih.gov/publications/surveillance112/HDS15.htm
   Google Scholar
• Freidlin, B., Korn, E. L., George, S. L., & Gray, R. (2007). Randomized clinical trial design for assessing noninferiority when superiority is expected. Journal of Clinical Oncology, 25(31), 5019–5023. https://doi.org/10.1200/JCO.2007.11.8711
   PubMed Web of Science ®Google Scholar
• Grant, B. F., Chou, S. P., Saha, T. D., Pickering, R. P., Kerridge, B. T., Ruan, W. J., Huang, B., Jung, J., Zhang, H., Fan, A., & Hasin, D. S. (2017). Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: Results From the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry, 74(9), 911–923. https://doi.org/10.1001/jamapsychiatry.2017.2161
   PubMed Web of Science ®Google Scholar
• Karam-Hage, M., & Brower, K. J. (2003). Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients. Psychiatry and Clinical Neurosciences, 57(5), 542–544. https://doi.org/10.1046/j.1440-1819.2003.01161.x
   PubMed Web of Science ®Google Scholar
• Levine, A. R., Carrasquillo, L., Mueller, J., Nounou, M. I., Naut, E. R., & Ibrahim, D. (2019). High-dose gabapentin for the treatment of severe alcohol withdrawal syndrome: A retrospective cohort analysis. Pharmacotherapy, 39(9), 881–888. https://doi.org/10.1002/phar.2309
   PubMed Web of Science ®Google Scholar
• Lindsay, D. L., Freedman, K., Jarvis, M., Lincoln, P., Williams, J., Nelson, L. S., & Safarian, T. (2020). Executive summary of the American Society of Addiction Medicine (ASAM) clinical practice guideline on alcohol withdrawal management. Journal of Addiction Medicine, 14(5), 376–392. https://doi.org/10.1097/adm.0000000000000732
   PubMed Web of Science ®Google Scholar
• Malcolm, R., Myrick, L. H., Veatch, L. M., Boyle, E., & Randall, P. K. (2007). Self-reported sleep, sleepiness, and repeated alcohol withdrawals: A randomized, double blind, controlled comparison of lorazepam vs gabapentin. Journal of Clinical Sleep Medicine, 3(1), 24–32.
   PubMed Web of Science ®Google Scholar
• Maldonado, J. R. (2017). Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes-beyond benzodiazepines. Critical Care Clinics, 33(3), 559–599. https://doi.org/10.1016/j.ccc.2017.03.012
   PubMed Web of Science ®Google Scholar
• Maldonado, J. R., Sher, Y., Das, S., Hills-Evans, K., Frenklach, A., Lolak, S., Talley, R., & Neri, E. (2015). Prospective validation study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in medically ill inpatients: A new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol and Alcoholism, 50(5), 509–518. https://doi.org/10.1093/alcalc/agv043
   PubMed Web of Science ®Google Scholar
• Markota, M., & Morgan, R. J. (2017). Treatment of generalized anxiety disorder with gabapentin. Case Reports in Psychiatry, 2017, 6045017. https://doi.org/10.1155/2017/6045017
   PubMedGoogle Scholar
• Mason, B. J., Quello, S., Goodell, V., Shadan, F., Kyle, M., & Begovic, A. (2014). Gabapentin treatment for alcohol dependence: A randomized clinical trial. JAMA Internal Medicine, 174(1), 70–77. https://doi.org/10.1001/jamainternmed.2013.11950
   PubMed Web of Science ®Google Scholar
• Myrick, H., Malcolm, R., Randall, P. K., Boyle, E., Anton, R. F., Becker, H. C., & Randall, C. L. (2009). A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcoholism, Clinical and Experimental Research, 33(9), 1582–1588. https://doi.org/10.1111/j.1530-0277.2009.00986.x
   PubMed Web of Science ®Google Scholar
• Nichols, T. A., Robert, S., Taber, D. J., & Cluver, J. (2019). Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility. The Mental Health Clinician, 9(1), 1–5. https://doi.org/10.9740/mhc.2019.01.001
   PubMedGoogle Scholar
• Pande, A. C., Davidson, J. R., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999). Treatment of social phobia with gabapentin: A placebo-controlled study. Journal of Clinical Psychopharmacology, 19(4), 341–348. https://doi.org/10.1097/00004714-199908000-00010
   PubMed Web of Science ®Google Scholar
• Rehm, J., Kailasapillai, S., Larsen, E., Rehm, M. X., Samokhvalov, A. V., Shield, K. D., Roerecke, M., & Lachenmeier, D. W. (2014). A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction, 109(6), 880–893. https://doi.org/10.1111/add.12498
   PubMed Web of Science ®Google Scholar
• Stock, C. J., Carpenter, L., Ying, J., & Greene, T. (2013). Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. The Annals of Pharmacotherapy, 47(7–8), 961–969. https://doi.org/10.1345/aph.1R751
   PubMed Web of Science ®Google Scholar
• Stuppaeck, C. H., Pycha, R., Miller, C., Whitworth, A. B., Oberbauer, H., & Fleischhacker, W. W. (1992). Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: A double-blind study. Alcohol and Alcoholism, 27(2), 153–158.
   PubMed Web of Science ®Google Scholar
• Vadiei, N., Smith, T. L., Walton, A. E., & Kjome, K. L. (2019). Impact of gabapentin adjunct use with benzodiazepines for the treatment of alcohol withdrawal in a psychiatric hospital. Psychopharmacology Bulletin, 49(1), 17–27.
   PubMedGoogle Scholar
• Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017). Gabapentin for chronic neuropathic pain in adults. The Cochrane Database of Systematic Reviews, 6(6), CD007938. https://doi.org/10.1002/14651858.CD007938.pub4
   PubMedGoogle Scholar